HTLV I+II p53 Ab:PrThr:Pt:Ser:Ord

Known as: HTLV 1+2 p53 Ac:PrThr:Temps ponctuel:Sérum:Ordinal, HTLV 1+2 p53 As:PrThr:Moment:Serum:Ordinaal, HTLV-1+2 p53 Ak:AKnz:Pkt:Ser:Ord 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2015
01219962015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE To investigate the effect of recombinant human p53 adenovirus injection combined with paclitaxel on human cervical… (More)
  • table I
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Exogenous wild-type p53 (wt-p53) tumor suppression increases the sensitivity of tumor cells to radiotherapy and chemotherapy. An… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2009
2009
PURPOSE To centrally assess the safety, efficacy, and 6-year follow-up of recombinant adenovirus-p53 (rAd-p53) combined with… (More)
Is this relevant?
2008
2008
In the present study, we have examined the safety and efficacy of recombinant adenovirus encoding human p53 tumor suppressor gene… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
PURPOSE To determine the feasibility, safety, humoral immune response, and biologic activity of multiple intratumoral injections… (More)
Is this relevant?
Review
2005
Review
2005
OVER THE PAST DECADE, gene therapy has been increasingly applied in clinical trials. According to data published by the Journal… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
2003
2003
Mutations of the tumor suppressor gene p53 are common in bladder cancer. To determine whether p53 gene transfer would lead to… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Acral myxoinflammatory fibroblastic sarcoma is a unique low-grade tumor of modified fibroblasts. It characteristically occurs in… (More)
Is this relevant?
1997
1997
Nasopharyngeal carcinoma (NPC) is a malignant disease of the head/neck region with a 5-year survival level of approximately 65… (More)
  • figure I
  • table I
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1996
1996
PURPOSE To test, in a clinical context, the hypothesis that p53 aberrations, assessed by immunoreactivity, are related to… (More)
Is this relevant?